Tech Company Financing Transactions

Nectin Therapeutics Funding Round

Israel Biotech Fund, Peregrine Ventures and aMoon Fund invested in a $25 million Series A funding round for Nectin Therapeutics. This VC investment round was announced on 11/30/2022.

Transaction Overview

Announced On
11/30/2022
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series A
Investors

Israel Biotech Fund (Lead Investor)

Peregrine Ventures (Lead Investor)

aMoon Fund

Proceeds Purpose
The funding will be used to support the ongoing clinical evaluation of NTX1088, and to further advance the company's pipeline of targeted immunotherapies and Antibody Drug Conjugates (ADCs).

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Hi -Tech Campus Givat Ram POB 39135
Jerusalem, 91390
IL
Email Address
Overview
Nectin Therapeutics is a biotechnology company devoted to transforming the lives of cancer patients by pioneering the development of next generation immune oncology (IO) therapies. Our differentiated therapies have the potential to set new standards for efficacy and patient response rates across various difficult-to-treat cancers. The company was established in 2017 based on seminal research at the Hebrew University of Jerusalem and the University of Rijeka. Our technology addresses major escape mechanisms of current IO therapies through a diverse pipeline of novel monoclonal antibodies (mAbs) and antibody-drug-conjugates (ADCs).
Profile
Nectin Therapeutics LinkedIn Company Profile
Social Media
Nectin Therapeutics Company Twitter Account
Company News
Nectin Therapeutics News
Facebook
Nectin Therapeutics on Facebook
YouTube
Nectin Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Fabian Tenenbaum
  Fabian Tenenbaum LinkedIn Profile  Fabian Tenenbaum Twitter Account  Fabian Tenenbaum News  Fabian Tenenbaum on Facebook
Chief Scientific Officer
Pini Tsukerman
  Pini Tsukerman LinkedIn Profile  Pini Tsukerman Twitter Account  Pini Tsukerman News  Pini Tsukerman on Facebook
VP - R & D
Guy Cinamon
  Guy Cinamon LinkedIn Profile  Guy Cinamon Twitter Account  Guy Cinamon News  Guy Cinamon on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/30/2022: Natron Energy venture capital transaction
Next: 11/30/2022: Midnight venture capital transaction

 

Share this article

 


About Database of VC Transactions

We report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary